Profile data is unavailable for this security.
About the company
Telesis Bio Inc. is a provider of ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) solutions. The Company provides automated multi-omic and synthetic biology solutions focused on providing applications to enable researchers to rapidly and reproducibly build or write high-quality synthetic DNA and messenger Ribonucleic Acid (mRNA) and short oligonucleotides that are ready to use in many downstream synthetic biology enabled markets. Its BioXp system consolidates, automates, and optimizes the entire synthesis, cloning and amplification workflow. Its on-market and its planned solutions include BioXp 3250 system, BioXp 9600 system, BioXp portal, BioXp De Novo kits, BioXp Select kits, BioXp Next Generation Sequencing kits, Benchtop reagents and Custom Gibson Short Oligo Ligation Assembly (SOLA) enzymatic DNA synthesis (EDS) solutions. BioXp Select kits offer customers the ability to use non-Telesis Bio DNA while using the BioXp system to perform synthetic biology workflow applications.
- Revenue in USD (TTM)16.28m
- Net income in USD-50.12m
- Incorporated2011
- Employees137.00
- LocationTelesis Bio Inc10431 Wateridge Circle, Suite 150SAN DIEGO 92121United StatesUSA
- Phone+1 (858) 228-4115
- Fax+1 (302) 636-5454
- Websitehttps://telesisbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Therapeutic Solutions International Inc | 91.38k | -2.00m | 3.91m | 3.00 | -- | 2.84 | -- | 42.76 | -0.0005 | -0.0005 | 0.00002 | 0.0003 | 0.0252 | 1.29 | 5.24 | 30,460.00 | -63.67 | -162.32 | -153.29 | -- | 65.18 | 67.79 | -2,530.31 | -2,391.85 | 0.3883 | -6.94 | 0.3164 | -- | -52.13 | 95.35 | 43.11 | -- | -- | -- |
| Kelyniam Global Inc | 517.70k | -420.28k | 3.94m | 0.00 | -- | 7.27 | -- | 7.60 | -0.0253 | -0.0253 | 0.0312 | 0.0179 | 0.4135 | 7.04 | 4.38 | -- | -33.57 | -- | -41.79 | -- | 18.86 | -- | -81.18 | -- | 1.26 | -- | 0.6232 | -- | -26.47 | -- | -19.10 | -- | -- | -- |
| Nu-Med Plus Inc | 0.00 | -112.13k | 4.18m | 2.00 | -- | -- | -- | -- | -0.0014 | -0.0014 | 0.00 | -0.0022 | 0.00 | -- | -- | 0.00 | -471.23 | -447.69 | -- | -- | -- | -- | -- | -- | -- | -21.34 | -- | -- | -- | -- | 3.56 | -- | -- | -- |
| AccuStem Sciences Inc | 0.00 | -1.65m | 4.43m | 3.00 | -- | -- | -- | -- | -0.1454 | -0.1454 | 0.00 | -0.2542 | 0.00 | -- | -- | 0.00 | -551.46 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 45.26 | -- | -- | -- |
| Encision Inc | 6.56m | -529.29k | 4.63m | 22.00 | -- | 2.49 | -- | 0.7056 | -0.045 | -0.045 | 0.556 | 0.1566 | 1.70 | 2.10 | 7.59 | 298,337.30 | -13.69 | -3.03 | -19.50 | -4.13 | 49.00 | 51.25 | -8.06 | -1.89 | 1.01 | -8.89 | 0.1761 | -- | -10.38 | -5.64 | -113.55 | -- | -9.54 | -- |
| Biomerica Inc | 5.41m | -5.98m | 4.72m | 63.00 | -- | 0.7162 | -- | 0.872 | -0.3554 | -0.3554 | 0.3218 | 0.3918 | 0.4566 | 2.17 | 6.49 | 85,920.63 | -50.43 | -44.68 | -61.13 | -51.73 | 11.23 | 14.11 | -110.44 | -63.82 | 2.43 | -- | 0.00 | -- | 1.42 | 0.8109 | 16.27 | -- | -7.64 | -- |
| Aethlon Medical, Inc. | 0.00 | -11.50m | 4.99m | 14.00 | -- | 0.5727 | -- | -- | -3.87 | -3.87 | 0.00 | 0.6251 | 0.00 | -- | -- | 0.00 | -84.49 | -76.25 | -98.84 | -85.78 | -- | -- | -- | -2,246.87 | -- | -- | 0.00 | -- | -100.00 | -- | -1.43 | -- | -- | -- |
| ADM Tronics Unlimited Inc | 3.06m | -472.80k | 5.07m | 7.00 | -- | 4.97 | -- | 1.66 | -0.007 | -0.007 | 0.0453 | 0.0151 | 1.11 | 3.72 | 5.67 | -- | -17.14 | -15.22 | -29.35 | -22.09 | 42.87 | 41.15 | -15.45 | -18.58 | 0.8954 | -- | 0.3259 | -- | -19.35 | -0.3572 | -810.74 | -- | -- | -- |
| Predictive Oncology Inc | 1.75m | -14.04m | 5.44m | 34.00 | -- | 1.14 | -- | 3.11 | -3.36 | -3.36 | 0.4158 | 0.7171 | 0.1108 | 1.45 | 4.28 | 51,425.29 | -88.98 | -91.80 | -121.17 | -126.29 | 60.23 | 64.64 | -802.93 | -1,419.99 | 1.37 | -- | 0.0634 | -- | 18.24 | 4.75 | 45.67 | -- | 5.44 | -- |
| Telesis Bio Inc | 16.28m | -50.12m | 5.48m | 137.00 | -- | -- | -- | 0.3365 | -29.66 | -30.68 | 9.61 | 5.61 | 0.1947 | 3.15 | 3.40 | 118,832.10 | -57.15 | -- | -64.21 | -- | 49.47 | -- | -293.54 | -- | 1.72 | -52.96 | 0.356 | -- | 0.2697 | -- | -1.14 | -- | -- | -- |
| BioSig Technologies Inc | 40.00k | -18.08m | 5.53m | 4.00 | -- | -- | -- | 138.37 | -1.97 | -1.97 | 0.0041 | 0.0066 | 0.0112 | -- | 1.07 | 10,000.00 | -489.14 | -269.73 | -4,711.71 | -363.11 | 65.00 | -- | -43,760.00 | -24,485.73 | -- | -3,115.67 | 0.00 | -- | -93.71 | -- | -6.52 | -- | -9.58 | -- |
| Reflect Scientific Inc | 1.73m | -53.09k | 5.57m | 7.00 | -- | 2.83 | 72.30 | 3.21 | -0.0006 | -0.0006 | 0.0203 | 0.023 | 0.7197 | 0.8463 | 17.05 | 247,638.60 | -2.20 | 11.10 | -2.59 | 13.21 | 58.19 | 62.48 | -3.06 | 10.00 | 5.68 | -- | 0.00 | -- | -47.09 | -6.99 | -613.46 | -- | -- | -- |
| Venus Concept Inc | 69.81m | -49.93m | 6.00m | 304.00 | -- | 1.62 | -- | 0.0859 | -8.38 | -8.38 | 11.92 | 0.5103 | 0.751 | 1.03 | 2.25 | 229,634.90 | -53.53 | -32.71 | -82.19 | -44.01 | 68.39 | 68.16 | -71.28 | -48.50 | 1.30 | -2.75 | 0.9133 | -- | -23.26 | 28.31 | 14.76 | -- | -35.08 | -- |
| Sharps Technology Inc | 0.00 | -8.21m | 6.75m | 3.00 | -- | 0.9353 | -- | -- | -0.4944 | -0.4944 | 0.00 | 0.2524 | 0.00 | -- | -- | -- | -75.56 | -- | -100.97 | -- | -- | -- | -- | -- | 0.6446 | -- | 0.00 | -- | -- | -- | -112.12 | -- | -- | -- |
| Caduceus Software Systems Corp | 0.00 | -117.60k | 7.17m | 0.00 | -- | -- | -- | -- | -0.0004 | -0.0004 | 0.00 | -0.0004 | 0.00 | -- | -- | -- | -402.19 | -11,090.31 | -- | -- | -- | -- | -- | -- | -- | -76.88 | -- | -- | -- | -- | -20,519.89 | -- | -- | -- |
| Biotricity Inc | 12.24m | -18.28m | 7.19m | 55.00 | -- | -- | -- | 0.5868 | -1.74 | -1.74 | 1.18 | -1.27 | 2.12 | 1.67 | 8.08 | 222,624.00 | -248.61 | -269.25 | -- | -- | 71.89 | 58.93 | -117.41 | -258.94 | 0.106 | -0.6408 | -- | -- | 25.15 | 97.82 | 23.57 | -- | -- | -- |
Data as of Sep 20 2024. Currency figures normalised to Telesis Bio Inc's reporting currency: US Dollar USD
1.59%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Millennium Management LLCas of 30 Jun 2024 | 12.91k | 0.73% |
| Abaris Investment Management AGas of 31 Dec 2023 | 11.95k | 0.67% |
| UBS Securities LLCas of 30 Jun 2024 | 2.46k | 0.14% |
| Merrill Lynch, Pierce, Fenner & Smith, Inc. (Invt Mgmt)as of 30 Jun 2024 | 278.00 | 0.02% |
| BG Fund Management Luxembourg SAas of 31 Dec 2023 | 237.00 | 0.01% |
| Dynamic Wealth Strategies LLCas of 30 Jun 2024 | 138.00 | 0.01% |
| Bank of America, NA (Private Banking)as of 30 Jun 2024 | 60.00 | 0.00% |
| JPMorgan Securities LLC (Investment Management)as of 30 Jun 2024 | 31.00 | 0.00% |
| RBC Dominion Securities, Inc.as of 30 Jun 2024 | 24.00 | 0.00% |
| Qube Research & Technologies Ltd.as of 30 Jun 2024 | 23.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 31 Jul 2024Source: FactSet Research Systems Inc.
